3-arylindole and 3-arylindazole derivatives
CA 2048027 C · Owner: Andersen, Kim · Inventors: Andersen, Kim; Perregaard, Jens Kristian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
3-Arylindole or 3-arylindazole derivatives having formula (see formula I), wherein Ar is optionally substituted phenyl or a heteroaromatic group; R1-R4 are independently selected from hydrogen halogen, alkyl, alkoxy, hydroxy, nitro alkylthio, alkylsulphonyl, alkyl- or dialkylamino cyano, trifluoromethyl, or, trifluoromethylthio; the dotted lines designate optional bonds; X is N or a group CR6 wherein R6 is hydrogen halogen, trifluoromethyl or , alkyl, or X is CH2; Y is N or CH, or Y is C;, R5 is hydrogen cycloalkyl, cycloalkylmethyl, alkyl or alkenyl optionally , substituted, with one or two hydroxy groups or R5 is a group taken from structures 1a and 1b:, (see formula 1a, 1b), wherein n …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 29, 1991 and granted October 30, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 29, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 29, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.